Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Pramipexole for opioid craving and relapse prevention
IRCT20210123050117N1Phase 3Completed
- Sponsor
- Kerman University of Medical Sciences
- Start
- Feb 2021
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, single-blind trial in opioid use disorder (OUD) comparing Pramipexole with Placebo (2 arms). Primary endpoints: Days of not abusing drugs, Frequency of craving and 1 more. Started Feb 2021; status: completed.
02
Drugs
pramipexole
03
Conditions
opioid use disorder (OUD)
Beyond the preview
Go deeper on IRCT20210123050117N1.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT20210123050117N1.